Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome.
about
Polycystic ovary syndrome: clinical implication in perimenopauseDyslipidemia in women with polycystic ovary syndromeMicrovascular dysfunction in women with polycystic ovary syndrome.Statins in the treatment of polycystic ovary syndrome.Polycystic ovarian syndrome: the metabolic syndrome comes to gynaecologySerum magnesium concentrations in polycystic ovary syndrome and its association with insulin resistance.Clinical management of PCOS.Comparison of four different treatment regimes in hirsutism related to polycystic ovary syndrome.Polycystic ovaries.Blood flow changes in the ovarian and uterine arteries in women with normal and polycystic ovaries.Obstructive sleep apnea and metabolic dysfunction in polycystic ovary syndromePolycystic ovary syndrome: not ovarian, not simple, unkind.Polycystic ovary syndrome and implications for the menopause.Polycystic ovary syndrome in women using valproate: a review.Polycystic ovary syndrome is associated with atherogenic changes in lipoprotein particle number and size independent of body weightEffect Of G2706A and G1051A polymorphisms of the ABCA1 gene on the lipid, oxidative stress and homocystein levels in Turkish patients with polycystıc ovary syndrome.Dyslipidemia and metabolic syndrome in the sisters of women with polycystic ovary syndromeAssociation of insulin resistance with lipid profile, metabolic syndrome, and hormonal aberrations in overweight or obese women with polycystic ovary syndrome.Liraglutide improves hypertension and metabolic perturbation in a rat model of polycystic ovarian syndrome.Ovarian hypertension: polycystic ovary syndrome.Metabolic dysfunction in obese Hispanic women with polycystic ovary syndrome.Aloe barbadensis Mill. formulation restores lipid profile to normal in a letrozole-induced polycystic ovarian syndrome rat model.Recent advances in the treatment of polycystic ovary syndrome.Insulin resistance in patients with polycystic ovary syndrome.A paradigm for finding genes for a complex human trait: polycystic ovary syndrome and follistatin.Cardiometabolic aspects of polycystic ovarian syndrome.Determinants of dyslipidaemia in probands with polycystic ovary syndrome and their sisters.Polycystic ovary syndrome, diabetes and cardiovascular disease: risks and risk factors.Cardiometabolic aspects of the polycystic ovary syndrome.Prevalence of metabolic syndrome in relation to body mass index and polycystic ovarian syndrome in Indian women.The metabolic syndrome in polycystic ovary syndrome.Polycystic Ovary Syndrome and Obstructive Sleep ApneaCardiovascular complications of obesity in adolescents.MicroRNA Species in Follicular Fluid Associating With Polycystic Ovary Syndrome and Related Intermediary Phenotypes.Targets to treat metabolic syndrome in polycystic ovary syndromePolycystic ovary syndrome (PCOS) and other androgen excess-related conditions: can changes in dietary intake make a difference?Adolescents with Classical Polycystic Ovary Syndrome Have Alterations in the Surrogate Markers of Cardiovascular Disease but Not in the Endothelial Function. The Possible Benefits of Metformin.Relationship between IL-17 serum level and ambulatory blood pressure in women with polycystic ovary syndrome.Metabolic syndrome and polycystic ovary syndrome... and vice versa.Insulin resistance and the long-term consequences of polycystic ovary syndrome.
P2860
Q26795581-4E7657CA-8BA7-454B-BF96-BF7125364A6DQ27025695-44D778D2-58DB-4BD1-98C5-2EC600611F4DQ33220101-D5D30E7C-7102-476F-BAF7-EB3EFC178579Q33789151-70B8E840-1E11-4F9C-A170-139DEE642A39Q33791299-B961E345-5177-47EF-B09D-7D147EC5C005Q34194665-4048B4FA-98E8-45DB-A55D-E7DFCCCAC676Q34352519-2E51EAF1-9F1E-430F-AC87-F71066550C33Q34406529-6AFD2025-7B96-4F61-AD33-84A73BCABAF3Q34503940-F638C165-CDF6-4378-A03C-4570C5C8AA57Q34530614-82DF117D-3472-4569-AC77-E3ECE0604CD7Q34536081-B9042D93-2CC7-45F7-9005-71A1536A7AD5Q34565871-588AD40C-6EF8-4293-8FDF-72A3551D87EFQ34575203-F15FD2E2-6B8E-4651-9F0E-94A8B1AAEC2DQ34881401-011ACB92-24F8-4FD7-987D-109C90864883Q35137659-20D17C26-17ED-4991-81EA-994FCA3A615FQ35560531-897052AF-B76C-41A1-A11E-3670D34C57AFQ35597070-C347B15B-3265-4D7A-A9D4-5E400A620EFFQ35627388-E70320B4-D4D4-4064-9D77-704F37B605D8Q35641060-1D401DC6-9EE5-41EB-A632-4D7FCE7C2A14Q35660296-C3448B19-B02F-4EF5-A6FB-FA6D100E7A07Q35837589-F683C85E-E057-4B48-928F-053F6C0B895BQ35890067-3F8FBBBD-ED2A-4135-9389-E080265B7842Q35906966-734241EC-7E0D-4A3B-AC08-2E1BE93AD87FQ35932352-42014371-6370-4D57-A36E-4CC549C6A6F0Q35992640-D6F7EC81-6141-4D0F-9325-03F8B8860439Q36013142-8A933639-A7EA-4CAC-94A3-3D9153B76811Q36222973-181A21EA-667E-4F72-9D09-519B90B0F5FDQ36251339-11DBD82E-0D33-40A1-B3AE-D133FEB97B9CQ36287892-A8B68C47-1852-4109-BB13-96BA7E643F1BQ36406472-DCCA5514-9D5A-45FD-A367-3F1C18E9AAB9Q36472269-9F2418AD-3D1D-408F-8F23-89DB91D85AF6Q36666354-15836DEF-65D4-42F2-A1F9-B613FD54B152Q36743491-C64AADFD-E9B5-45D0-9081-CEED649B81D0Q36935580-F7DD33CB-3015-4D3C-A1B6-B1443B4004E5Q36943683-93290D97-4BFE-4B5B-B7D7-1B6E33414A73Q37060111-7D8F30C8-0297-4C3A-9B8E-FAD04B0BF150Q37214728-6DF351B7-48ED-477B-BA37-E4AE9DF537E2Q37410552-FA3C6614-02F5-417C-9FB4-42AA6978F4A6Q37494304-DA24B36B-913D-42C6-B8BD-B67179C0417DQ37833622-2B5A3293-CB11-4CBA-81CB-93C090141DED
P2860
Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Risk factors for coronary arte ...... the polycystic ovary syndrome.
@en
Risk factors for coronary arte ...... the polycystic ovary syndrome.
@nl
type
label
Risk factors for coronary arte ...... the polycystic ovary syndrome.
@en
Risk factors for coronary arte ...... the polycystic ovary syndrome.
@nl
prefLabel
Risk factors for coronary arte ...... the polycystic ovary syndrome.
@en
Risk factors for coronary arte ...... the polycystic ovary syndrome.
@nl
P2093
P2860
P1476
Risk factors for coronary arte ...... the polycystic ovary syndrome.
@en
P2093
Betteridge DJ
P2860
P304
P356
10.1111/J.1365-2265.1992.TB02295.X
P577
1992-08-01T00:00:00Z